Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Izzy who wrote (5250)	9/2/1998 11:42:00 PM
From: George T. Santamaria	Read Replies (2) of 6136

Guess I have to say that the proposal sounds a little flaky! Seems like they will be diluting the hell out of the current float and leaving a lot of the shares out for an undesignated purpose. Maybe that will help mgt. to further enrich themselves while diluting our equity. They are fat enough, in my opinion. It's hard to believe that that with a common infrastructure, shared mgt. and a lot of shared resources, that the performance tracking will be very accurate. Just by the allocation of expenses such as the maintenance of what will be common facilities, they have broad latitude to cook the books. I think that management, in spite of their successes, still has a lot of accountability to their basic mission, which used to be building an R&D pipeline which cranks out two products a year. Let's hope that they are not losing their way. Agouron still has to deliver on AG3340 in a timely manner and the divisional proposal won't change a thing. Vote Nay!

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next